Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „majority“
Suchtreffer
Begriffe & Kennungen
Emgality · 4.8 · Injection site pain or reactions The majority of reactions related to the injection site were mild to moderate
Eintrag öffnenEmgality · 4.8 · Injection site pain or reactions The majority of reactions related to the injection site were mild to moderate
Eintrag öffnenEnbrel · 4.8 · 103 month. Mean duration was approximately 3 to 5 days. No treatment was given for the majority of injection s
Eintrag öffnenEnspryng · 4.8 · The majority of the decreased platelets were transient and not below 75 × 109/l.
Eintrag öffnenEptifibatide Accord · 4.8 · Blood and lymphatic system disorders Very rare Fatal bleeding (the majority involved central and peripheral ne
Eintrag öffnenEptifibatide Accord · 4.8 · Blood and lymphatic system disorders Very rare Fatal bleeding (the majority involved central and peripheral ne
Eintrag öffnenEptifibatide Accord · 4.8 · The majority of adverse reactions experienced by patients treated with eptifibatide were generally related to
Eintrag öffnenEptifibatide Accord · 4.8 · The majority of adverse reactions experienced by patients treated with eptifibatide were generally related to
Eintrag öffnenEtcamah · 4.8 · Visual effects Of the 40.7% patients who reported visual effects, the majority (92.5%) experienced CTCAE Grade
Eintrag öffnenEucreas · 4.8 · The majority of adverse reactions were mild and transient, not requiring treatment discontinuations. No associ
Eintrag öffnenEvoltra · 4.8 · 9 which were considered to be serious; see section 4.4). However, the majority of these hypotensive events wer
Eintrag öffnenFirazyr · 4.8 · The majority of paediatric patients who were treated with subcutaneous icatibant experienced injection site re
Eintrag öffnenFoclivia · 4.8 · The majority of these reactions usually disappear within 3 days without treatment.
Eintrag öffnenFoclivia · 4.8 · The majority of these reactions usually disappear within 3 days without treatment.
Eintrag öffnenFuzeon · 4.8 · The majority of patients had no change in the toxicity grade of any laboratory parameter during the study exce
Eintrag öffnenGalvus · 4.8 · The majority of adverse reactions in these trials were mild and transient, not requiring treatment discontinua
Eintrag öffnenGanfort · 4.8 · The majority of adverse reactions reported in clinical studies using GANFORT were ocular, mild in severity and
Eintrag öffnenGanfort · 4.8 · The majority of adverse reactions reported with GANFORT single-dose were ocular, mild in severity and none wer
Eintrag öffnenIcandra (previously Vildagliptin / metformin hydrochloride Novartis) · 4.8 · The majority of adverse reactions were mild and transient, not requiring treatment discontinuations. No associ
Eintrag öffnenItuxredi · 4.8 · Neutropenia Events of neutropenia were observed with rituximab treatment, the majority of which were transient
Eintrag öffnen